The prevalence and clinical significance of residual occult breast cancer after neoadjuvant chemotherapy: reassessing surgical pathology in cases initially described as pathological complete response.

Saved in:
Bibliographic Details
Title: The prevalence and clinical significance of residual occult breast cancer after neoadjuvant chemotherapy: reassessing surgical pathology in cases initially described as pathological complete response.
Authors: Ai D; Department of Pathology and Laboratory Medicine, McGovern School of Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA., Arrey EN; Department of Surgery, Morehouse School of Medicine, Atlanta, GA, USA., Postlewait LM; Division of Surgical Oncology, Department of Surgery, Grady Memorial Hospital, Emory University, Atlanta, GA, USA., Gao Y; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, USA., Li X; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, USA.
Source: Histopathology [Histopathology] 2025 Jun; Vol. 86 (7), pp. 1112-1120. Date of Electronic Publication: 2025 Feb 04.
Publication Type: Journal Article
Journal Info: Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 7704136 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2559 (Electronic) Linking ISSN: 03090167 NLM ISO Abbreviation: Histopathology Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1365-2559
DOI:10.1111/his.15417